Atrial gap junctions, NF-κB and fibrosis in patients undergoing coronary artery bypass surgery: The relationship with postoperative atrial fibrillation

Cardiology

Volumn 112, Issue 2, 2008, Pages 81-88

  Li, Jiun Yi ^a   Lai, Yu Jun ^a   Yeh, Hung I ^a,b   Chen, Chia Li ^a   Sun, Shen ^a   Wu, Shye Jao ^a   Lin, Fang Yue ^c  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Atrial fibrillation; Connexins; Fibrosis; Inflammation

Indexed keywords

CONNEXIN 40; CONNEXIN 43; GAP JUNCTION PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FIBROSIS; GAP JUNCTION; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART BEAT; HEART SURGERY; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINUS RHYTHM;

AGED; ATRIAL FIBRILLATION; CONNEXIN 43; CONNEXINS; CORONARY ARTERY BYPASS, OFF-PUMP; FEMALE; FIBROSIS; GAP JUNCTIONS; HEART ARREST, INDUCED; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; NF-KAPPA B; POSTOPERATIVE COMPLICATIONS;

EID: 58149086016     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000141012     Document Type: Article

References (25)

1. Herve JC, Dhein S: Pharmacology of cardiovascular gap junctions. Adv Cardiol 2006;42:107-131.
2. Severs NJ, Coppen SR, Dupont E, Yeh HI, Ko YS, Matsushita T: Gap junction alterations in human cardiac disease. Cardiovasc Res 2004;62:368-377.
3. Almassi GH, Schowalter T, Nicolosi AC, Aggarwal A, Moritz TE, Henderson WG, Tarazi R, Shroyer AL, Sethi GK, Grover FL, Hammermeister KE: Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg 1997;226:501-511.
4. Maisel WH, Rawn JD, Stevenson WG: Atrial fibrillation after cardiac surgery. Ann Intern Med 2001;135:1061-1073.
5. Kalus JS, White CM, Caron MF, Coleman CI, Takata H, Kluger J: Indicators of atrial fibrillation risk in cardiac surgery patients on prophylactic amiodarone. Ann Thorac Surg 2004;77:1288-1292.
6. Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM: Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997;96:2455-2461.
7. Yeh HI, Hou SH, Hu HR, Lee YN, Li JY, Dupont E, Coppen SR, Ko YS, Severs NJ, Tsai CH: Alteration of gap junctions and connexins in the right atrial appendage during cardiopulmonary bypass. J Thorac Cardiovasc Surg 2002;124:1106-1112.
8. Athanasiou T, Aziz O, Mangoush O, Al-Ruzzeh S, Nair S, Malinovski V, Casula R, Glenville B: Does off-pump coronary artery bypass reduce the incidence of post-operative atrial fibrillation? A question revisited. Eur J Cardiothorac Surg 2004;26:701-710.
9. Magee MJ, Jablonski KA, Stamou SC, Pfister AJ, Dewey TM, Dullum MK, Edgerton JR, Prince SL, Acuff TE, Corso PJ, Mack MJ: Elimination of cardiopulmonary bypass improves early survival for multivessel coronary artery bypass patients. Ann Thorac Surg 2002;73:1196-1202.
10. Cheng DC, Bainbridge D, Martin JE, Novick RJ: Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials. Anesthesiology 2005;102:188-203.
11. Reston JT, Tregear SJ, Turkelson CM: Metaanalysis of short-term and mid-term outcomes following off-pump coronary artery bypass grafting. Ann Thorac Surg 2003;76:1510-1515.
12. Boos CJ, Anderson RA, Lip GY: Is atrial fibrillation an inflammatory disorder? Eur Heart J 2006;27:136-149.
13. Engelmann MD, Svendsen JH: Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005;26:2083-2092.
14. Chanson M, Berclaz PY, Scerri I, Dudez T, Wernke-Dollries K, Pizurki L, Pavirani A, Fiedler MA, Suter S: Regulation of gap junctional communication by a pro-inflammatory cytokine in cystic fibrosis transmembrane conductance regulator-expressing but not cystic fibrosis airway cells. Am J Pathol 2001;158:1775-1784.
15. Yamamoto T, Kojima T, Murata M, Takano K, Go M, Chiba H, Sawada N: IL-1β regulates expression of Cx32, occludin, and claudin-2 of rat hepatocytes via distinct signal transduction pathways. Exp Cell Res 2004;299:427-441.
16. Yeh HI, Lai YJ, Lee YN, Chen YJ, Chen YC, Chen CC, Chen SA, Lin CI, Tsai CH: Differential expression of connexin43 gap junctions in cardiomyocytes isolated from canine thoracic veins. J Histochem Cytochem 2003;51:259-266.
17. Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT: Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005;95:764-767.
18. Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H: High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 2006;108:346-353.
19. Kamiyama N: Expression of cell adhesion molecules and the appearance of adherent leukocytes on the left atrial endothelium with atrial fibrillation: rabbit experimental model. Jpn Circ J 1998;62:837-843.
20. Nakamura Y, Nakamura K, Fukushima-Kusano K, Ohta K, Matsubara H, Hamuro T, Yutani C, Ohe T: Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis. Thromb Res 2003;111:137-142.
21. Nam NH: Naturally occurring NF-κB inhibitors. Mini Rev Med Chem 2006;6:945-951.
22. Dupont E, Ko Y, Rothery S, Coppen SR, Baghai M, Haw M, Severs NJ: The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation 2001;103:842-849.
23. Meiners S, Hocher B, Weller A, Laule M, Stangl V, Guenther C, Godes M, Mrozikiewicz A, Baumann G, Stangl K: Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome. Hypertension 2004;44:471-477.
24. Barnes BJ, Kirkland EA, Howard PA, Grauer DW, Gorton ME, Kramer JB, Muehlebach GF, Reed WA: Risk-stratified evaluation of amiodarone to prevent atrial fibrillation after cardiac surgery. Ann Thorac Surg 2006;82:1332-1337.
25. Behmanesh S, Tossios P, Homedan H, Hekmat K, Hellmich M, Muller-Ehmsen J, Schwinger RH, Mehlhorn U: Effect of prophylactic bisoprolol plus magnesium on the incidence of atrial fibrillation after coronary bypass surgery: results of a randomized controlled trial. Curr Med Res Opin 2006;22:1443-1450.